perimenopausal dry eyes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with dry eye. 2. Perimenopausal(Ages 40-55) women who meet the syndrome of kidney deficiency and liver stagnation. 3. Patients who are currently using artificial tears or anti-inflammatory eye drops should wait for one week after discontinuing the medication before being included. 4. Participants have signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with scleral scarring Sjogren's syndrome or severe meibomian glanditis. 2. Patients with glaucoma who require topical hypotensive medication to control intraocular pressure. 3. Perimenopausal women with emotional disorders or severe cardiovascular cerebrovascular or liver and kidney diseases with liver and kidney function exceeding normal values by 2 times or more. 4. Patients who have used sex hormones within the past 3 months. 5. Patients who are currently participating in other drug clinical trials or who are taking similar Chinese herbal medicines and other treatments. 6. Patients who do not wish to participate in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tear film rupture time;Ocular symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| General Symptom Score;Tear secretion function;Meibomian gland deletion score;Lipid layer score;Conjunctival imprinted cell count and inflammatory factor expression levels;Sex hormone and anti-Miller hormone levels;Conjunctival congestion score;Lacrimal river height;Dry eye related quality of life score;Corneal epithelial status; | — |
Countries
China
Contacts
Eye Hospital China Academy of Chinese Medical Sciences